Inside this portfolio
Identified stock classes25
Matched (%)99.51%
| Largest reported stocks | Portfolio weight |
|---|---|
| Eli Lilly & Co | 20.23% |
| Novartis AG | 10.63% |
| Merck & Co Inc | 9.85% |
| Novo Nordisk A/S | 5.37% |
| AbbVie Inc | 4.57% |
How to read these numbers
The day the fund recorded its holdings.
The share of the fund’s net assets that we could identify as common-stock classes.
Holdings history
28 portfolio dates–
Choose a portfolio date to see which stocks had the largest weights then.